Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases – author's reply

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2036|42|1|120-120

ISSN: 0269-2813

Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.1, 2015-07, pp. : 120-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract